Plant-Derived Analgesics Market Forecast Insights: The Road To $5.06 Billion By 2030
Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Plant-Derived Analgesics Market Forecast: Value Set To Climb From $3.66 Billion To $5.06 Billion
The plant-derived analgesics market has seen significant growth in recent years. This market is expected to expand from $3.39 billion in 2025 to $3.66 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.2%. Historically, this growth can be linked to the embrace of traditional medicine, a rising need for natural pain relief, the increasing consumption of herbal supplements, worries regarding opioid side effects, and the broadening of botanical extraction methods.
The plant-derived analgesics market is anticipated to experience robust expansion over the next few years. It is projected to grow to $5.06 billion in 2030, at a compound annual growth rate (CAGR) of 8.4%. This growth during the forecast period can be attributed to an increasing preference for natural therapeutics, the expansion of cannabinoid medicines, a growing pipeline of plant based drugs, enhanced clinical validation of botanicals, and wider adoption of integrative care. Major trends expected in this period include standardized botanical pain extracts, the isolation of high purity phytochemicals, combination herbal analgesic formulas, plant actives with enhanced bioavailability, and evidence based botanical therapies.
Get A Free Sample Report With In-Depth Market Insights:
Plant-Derived Analgesics Market Industry Drivers: What’s Behind The Revenue Growth?
The anticipated expansion of the plant-derived analgesics market is significantly influenced by the escalating occurrence of chronic pain conditions. These persistent pain disorders encompass musculoskeletal pain, arthritis, neuropathic pain, and inflammatory conditions, all necessitating continuous management. Globally, the incidence of chronic pain is on the rise, attributed to factors such as aging demographics, inactive lifestyles, higher obesity levels, and an increasing burden of various chronic diseases. Plant-derived analgesics provide support in handling these conditions by supplying pain relief choices crafted from botanical extracts, herbs, and active plant compounds, which are progressively adopted as supplementary or alternative pain management treatments. As an illustration, data from November 2024 by the Centers for Disease Control and Prevention (CDC), a US-based federal public health agency, indicated that in 2023, approximately 24.3% of adults in the United States suffered from chronic pain, with 8.5% experiencing high-impact chronic pain. Consequently, the widening prevalence of chronic pain conditions throughout key healthcare markets is a primary factor stimulating the growth of the plant-derived analgesics market.
Plant-Derived Analgesics Market Segment Analysis Spotlighting Growth Areas
The plant-derived analgesics market covered in this report is segmented –
1) By Product Type: Morphine; Codeine; Salicin; Cannabinoids; Curcumin
2) By Formulation Type: Tablets; Capsules; Creams; Injectable Forms; Oils
3) By Source: Plant-derived opioid alkaloids; Salicylate-type analgesics; Cannabinoids And hemp-derived; Polyphenolic; Other phytochemicals
4) By Sales Channel: Hospitals; Clinics; Retail Sales; Online Sales; Hypermarkets And Supermarkets
5) By Application: Chronic Pain Management; Acute Pain Relief; Post-Surgical Pain; Neuropathic Pain
Subsegments:
1) By Morphine: Immediate Release Formulations; Extended Release Formulations; Injectable Preparations; Oral Solid Dosage Forms
2) By Codeine: Single Ingredient Analgesics; Combination Pain Relief Products; Oral Solid Dosage Forms; Liquid Oral Formulations
3) By Salicin: Standardized Plant Extracts; Oral Solid Dosage Forms; Liquid Herbal Preparations; Combination Botanical Formulations
4) By Cannabinoids: Tetrahydrocannabinol Dominant Products; Cannabidiol Dominant Products; Balanced Cannabinoid Formulations; Full Spectrum Plant Extracts
5) By Curcumin: Standard Curcumin Extracts; Enhanced Bioavailability Formulations; Combination Herbal Products; Oral Solid Dosage Forms
#Plant-Derived Analgesics Market Growth Trends: What’s Shaping The Future Outlook?
Leading companies within the plant-derived analgesics market are concentrating on technological improvements in techniques for botanical extraction, purification, and formulation. This includes developing plant-based formulations and enhancing bioavailability, all with the goal of minimizing batch-to-batch variations and boosting both regulatory and consumer acceptance. Plant-based formulation and bioavailability enhancement specifically denote the scientific fine-tuning of analgesic products sourced from plants, utilizing sophisticated formulation methods engineered to better the stability, solubility, and absorption of active botanical compounds. This supports more reliable product performance and more effective therapeutic delivery. For example, in January 2023, Medterra CBD, LLC., a US-based botanical wellness company, released its Natural Pain Relief capsules to offer consumers wider access to plant-derived solutions for pain management. The Natural Pain Relief capsules are marketed as a plant-based, non-opioid choice for managing pain, formulated with standardized botanical ingredients like turmeric and Levagen+ palmitoylethanolamide (PEA), designed to boost bioavailability and help relieve muscle pain, joint stiffness, and inflammation.
Plant-Derived Analgesics Market Leading Companies And Competitive Benchmarking
Major companies operating in the plant-derived analgesics market are Dabur India Limited, Patanjali Ayurved Limited, Blackmores Limited, Bionorica SE, Emami Limited, Himalaya Wellness Company, Biologische Heilmittel Heel GmbH, Charak Pharma Private Limited, Indena S.p.A., Nature’s Way Products LLC, Arya Vaidya Sala Kottakkal, Gaia Herbs Farm Inc., Hamdard Laboratories (India), Shree Dhootapapeshwar Limited, Sri Sri Tattva, Euromed S.A., Sami-Sabinsa Group Limited, Martin Bauer Group, Shree Baidyanath Ayurved Bhawan Private Limited, Organic India Private Limited
View The Full Plant-Derived Analgesics Market Report:
Plant-Derived Analgesics Market Largest Region By Revenue And Market Share
North America was the largest region in the plant-derived analgesics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the plant-derived analgesics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model